Početna stranicaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
197,77 $
Poslije radnog vremena:(0,00 %)0,00
197,77 $
Zatvoreno: 18. lis, 17:52:53 GMT -4 · USD · NYSE · Odricanje od odgovornosti
Preth. zaklj. cijena
197,78 $
Dnevni raspon
195,76 $ - 200,52 $
Godišnji raspon
161,65 $ - 275,00 $
Tržišna kapitalizacija
10,21 mlr. USD
Prosječna količina
639,88 tis.
P/E omjer
23,62
Prinos dividende
-
Glavno tržište vrijednosnica
NYSE
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
(USD) | lip 2024.info | Godišnja promjena |
---|---|---|
Prihod | 1,03 mlr. | −3,19 % |
Operativni troškovi | 197,42 mil. | −14,98 % |
Neto dohodak | 94,08 mil. | −3,03 % |
Neto profitabilnost | 9,17 | 0,22 % |
Zarada po dionici | 2,80 | 4,09 % |
EBITDA | 256,39 mil. | 3,79 % |
Efektivna porezna stopa | 21,22 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
(USD) | lip 2024.info | Godišnja promjena |
---|---|---|
Gotovinska i kratkoročna ulaganja | 179,21 mil. | −10,59 % |
Ukupna imovina | 7,95 mlr. | 2,26 % |
Ukupne obveze | 4,18 mlr. | −6,65 % |
Ukupni kapital | 3,77 mlr. | — |
Dionice u optjecaju | 51,63 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 2,74 | — |
Povrat imovine | 5,29 % | — |
Povrat kapitala | 6,35 % | — |
Tok novca
Neto promjena novca
(USD) | lip 2024.info | Godišnja promjena |
---|---|---|
Neto dohodak | 94,08 mil. | −3,03 % |
Gotovina od poslovanja | 193,54 mil. | 30,66 % |
Gotovina iz ulaganja | −61,87 mil. | 19,24 % |
Gotovina iz financiranja | −285,86 mil. | −300,00 % |
Neto promjena novca | −157,53 mil. | −138.085,09 % |
Slobodan tok novca | 145,77 mil. | 120,91 % |
Više
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
According to the company, it supported the development of approximately 85% of novel FDA-approved drugs in 2021.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Glavni izvršni direktor
Osnovano
1947
Web-lokacija
Zaposlenici
21.100